<DOC>
	<DOCNO>NCT01574365</DOCNO>
	<brief_summary>A Phase 2 study RTA 402 Chronic kidney disease ( CKD ) patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>A Study RTA 402 Chronic Kidney Disease ( CKD ) Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>To evaluate efficacy safety RTA 402 patient type 2 diabetes mellitus . To evaluate safety tolerability RTA 402 .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>CKD patient type 2 diabetes mellitus Patients whose eGFR level eligible study Patients treat stable dose ACE inhibitor and/or ARB etc . Patients Type 1 diabetes Patients know nondiabetic renal disease Patients history renal transplantation Patients mean SBP &gt; 160 mmHg mean DBP &gt; 90 mmHg Patients HbA1C &gt; 10 % Patients cardiovascular disease specify study protocol etc .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>CKD patient type 2 diabetes</keyword>
</DOC>